Actelion reports stronger-than-expected switch from Tracleer into Opsumit in NRx in the US

BUY, Fair Value CHF75 (-6%)

News published on January Tuesday 14, 2014
Share on

The Essentials

Everything you need to know about investment banking dedicated to growth
Recent Transactions Highlights
From M&A, to IPOs see what’s been happening at Bryan, Garnier & Co this year
Join our Team
Bryan, Garnier & Co is always looking for talent in all our divisions, at all levels
Explore our opportunities